Your browser doesn't support javascript.
loading
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.
Chang, Anne Lynn S; Tran, Duy C; Cannon, John G D; Li, Shufeng; Jeng, Mark; Patel, Roma; Van der Bokke, Lindsay; Pague, Alana; Brotherton, Richard; Rieger, Kerri E; Satpathy, Ansuman T; Yost, Kathryn E; Reddy, Sunil; Sarin, Kavita; Colevas, A Dimitrios.
Afiliación
  • Chang ALS; Department of Dermatology, Stanford University School of Medicine, Stanford, California. Electronic address: alschang@stanford.edu.
  • Tran DC; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Cannon JGD; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Li S; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Jeng M; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Patel R; Stanford Cancer Institute, Cancer Clinical Trials Office, Stanford, California.
  • Van der Bokke L; Stanford Cancer Institute, Cancer Clinical Trials Office, Stanford, California.
  • Pague A; Stanford Cancer Institute, Cancer Clinical Trials Office, Stanford, California.
  • Brotherton R; Stanford Cancer Institute, Cancer Clinical Trials Office, Stanford, California.
  • Rieger KE; Stanford Dermatopathology Service, Department of Pathology, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California.
  • Satpathy AT; Department of Epithelial Biology, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California.
  • Yost KE; Department of Epithelial Biology, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California.
  • Reddy S; Department of Medicine/Medical Oncology, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California.
  • Sarin K; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Colevas AD; Department of Medicine/Medical Oncology, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, California.
J Am Acad Dermatol ; 80(2): 564-566, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30145186
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piridinas / Neoplasias Cutáneas / Carcinoma Basocelular / Anticuerpos Monoclonales Humanizados / Anilidas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piridinas / Neoplasias Cutáneas / Carcinoma Basocelular / Anticuerpos Monoclonales Humanizados / Anilidas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Am Acad Dermatol Año: 2019 Tipo del documento: Article